TSX-V:AQS • CA0076361033
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Aequus Pharmaceuticals Inc (AQS.CA).
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.715M 4.71% | 1.38M -49.17% | 254.9K -81.53% | |
| EBITDA YoY % growth | -1.239M -270.60% | -2.368M -91.09% | -2.682M -13.25% | |
| EBIT YoY % growth | -1.367M -150.72% | -2.498M -82.68% | -2.82M -12.90% | |
| Operating Margin | -50.37% | -181.04% | -1,106.43% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Aequus Pharmaceuticals Inc (AQS.CA) will report earnings on 2025-05-07.